Functional network analysis of gene-phenotype connectivity associated with temozolomide

Jia Shi; Bo Dong; Peng Zhou; Wei Guan; Ya Peng

doi:10.18632/oncotarget.20848

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Functional network analysis of gene-phenotype connectivity associated with temozolomide

Jia Shi, Bo Dong, Peng Zhou, Wei Guan _ and Ya Peng

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:87554-87567. https://doi.org/10.18632/oncotarget.20848

Metrics: PDF 1969 views | HTML 2871 views | ?

Abstract

Jia Shi1,*, Bo Dong1,*, Peng Zhou1,*, Wei Guan1 and Ya Peng1

1Department of Neurosurgery, The Third Affiliated Hospital of Soochow University, Changzhou City, 213003, China

*These authors have contributed equally to this work

Correspondence to:

Wei Guan, email: [email protected]

Ya Peng, email: [email protected]

Keywords: temozolomide, glioma, TP53

Received: June 26, 2017 Accepted: August 17, 2017 Published: September 12, 2017

ABSTRACT

Rationale: Glioma has a poor survival rate in patients even with aggressive treatment. Temozolomide (TMZ) is the standard chemotherapeutic choice for treating glioma, but TMZ treatment consistently leads to high resistance.

Aim: To investigate the underlying mechanisms of TMZ action with new therapeutic regimens in glioma.

Methods and results: The biological effects of TMZ mainly depend on the three following DNA repair systems: methylguanine methyltransferase (MGMT), mismatch repair (MMR) and base excision repair (BER). Based on related genes in these three systems, web-based tools containing data compiled from open-source databases, including DrugBank, STRING, WebGestalt and ClueGO, were queried, and five common genes along with the top fifteen pathways, including the glioma pathway, were identified. A genomic analysis of the six genes identified in the glioma pathway by cBioPortal indicated that TMZ might exert biological effects via interaction with the tumor protein P53(TP53) signaling axis. Finally, a survival analysis with the six genes in glioma cases (low-grade glioma and glioblastoma multiforme) was conducted using OncoLnc, which might provide directions for the future exploration of prognosis in glioma.

Conclusions: This study indicates that a functional network analysis resembles a “BioGPS”, with the ability to draw a web-based scientific map that can productively and cost-effectively associate TMZ with its primary and secondary biological targets.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 20848

Publication Alerts

Research Papers:

Functional network analysis of gene-phenotype connectivity associated with temozolomide

Abstract